The World Boxing Council determined that Conor Benn’s failed drugs test was not deliberate and could have been brought on by a “highly-elevated consumption” of eggs. As a result, Conor Benn is back in the rankings.
Before his postponed October fight with Chris Eubank Jr., Benn failed two voluntary drug tests for the female reproductive medication clomifene.
He is still being looked at by UK Anti-Doping and the British Board of Boxing Control, and since he lacks a boxing license, he cannot compete in fights in the United Kingdom.
The bout between Benn and Eubank was slated to take place on October 8 at 157 pounds, 30 years after their dads Nigel Benn and Chris Eubank Sr. squared off.
The 26-year-old has previously attributed the results to “contamination.” His defense claimed that the VADA testing laboratory was at fault, but the WBC disagreed.
The regulating committee concluded that “there was no conclusive evidence that Mr. Benn engaged in intentional or knowing consumption of clomifene,” according to a detailed statement.
It continued: “There were no violations of Mr. Benn’s B Sample rights or errors in the processes related to sample collection or analysis that would support challenging or invalidating the adverse finding, and Mr. Benn’s documented and elevated egg consumption during the times relevant to the sample collection raised a plausible explanation for the adverse finding.”
The statement alludes to a test that was administered on July 25th, after Benn’s enrollment in the WBC’s out-of-competition testing program in July.
He tested positive for the hydroxymetabolites MI and M2 of clomifene. The WBC believes it did not receive “substantive response” from Benn until December and the WBC did not complete a full analysis until January 2023.